Response to: Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al

John H. Stone, Mollie N. Carruthers, Mark D. Topazian, Arezou Khosroshahi, Thomas E. Witzig, Zachary S. Wallace, Phillip A. Hart, Vikram Deshpande, Thomas C. Smyrk, Suresh Chari

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Response to: Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al'. Together they form a unique fingerprint.